According to this latest study, the 2021 growth of Vaccine will have significant change from previous year. By the most conservative estimates of global Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Varicella Vaccine

Influenza Vaccine

Polio Vaccine

Hepatitis A Vaccine

Rabies Vaccine

BCG Vaccine

Hepatitis B

Pertussis, Diphtheria, Tetanus

Pneumococcal

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

For Adult

For Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

AstraZeneca

BioNTech

Boehringer-Ingelheim

CCBIO

CSL

CureVac

Elanco

GSK

Hulan Bio

Indian Immunologicals

Merck

Minhai Biotechnology

Mitsubishi Tanabe Pharma

Moderna Therapeutics

Mylan

Plumbline Life Sciences

Sanofi

Translate Bio

Walvax Biotechnology

Wuhan Institute of Biological Products

Zoties

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccine Market Size 2016-2026

2.1.2 Vaccine Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Vaccine Segment by Type

2.2.1 Varicella Vaccine

2.2.2 Varicella Vaccine

2.2.3 Polio Vaccine

2.2.4 Hepatitis A Vaccine

2.2.5 Rabies Vaccine

2.2.6 BCG Vaccine

2.2.7 Hepatitis B

2.2.8 Pertussis, Diphtheria, Tetanus

2.2.9 Pneumococcal

2.2.10 Others

2.3 Vaccine Market Size by Type

2.3.1 Global Vaccine Market Size CAGR by Type

2.3.2 Global Vaccine Market Size Market Share by Type (2016-2021)

2.4 Vaccine Segment by Application

2.4.1 For Adult

2.4.2 For Child

2.5 Vaccine Market Size by Application

2.5.1 Global Vaccine Market Size CAGR by Application

2.5.2 Global Vaccine Market Size Market Share by Application (2016-2021)

3 Vaccine Market Size by Players

3.1 Vaccine Market Size Market Share by Players

3.1.1 Global Vaccine Revenue by Players (2019-2021E)

3.1.2 Global Vaccine Revenue Market Share by Players (2019-2021E)

3.2 Global Vaccine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Vaccine by Regions

4.1 Vaccine Market Size by Regions (2016-2021)

4.2 Americas Vaccine Market Size Growth (2016-2021)

4.3 APAC Vaccine Market Size Growth (2016-2021)

4.4 Europe Vaccine Market Size Growth (2016-2021)

4.5 Middle East & Africa Vaccine Market Size Growth (2016-2021)

5 Americas

5.1 Americas Vaccine Market Size by Country (2016-2021)

5.2 Americas Vaccine Market Size by Type (2016-2021)

5.3 Americas Vaccine Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccine Market Size by Region (2016-2021)

6.2 APAC Vaccine Market Size by Type (2016-2021)

6.3 APAC Vaccine Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Vaccine by Country (2016-2021)

7.2 Europe Vaccine Market Size by Type (2016-2021)

7.3 Europe Vaccine Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccine by Region (2016-2021)

8.2 Middle East & Africa Vaccine Market Size by Type (2016-2021)

8.3 Middle East & Africa Vaccine Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Vaccine Market Forecast

10.1 Global Vaccine Forecast by Regions (2021-2026)

10.1.1 Global Vaccine Forecast by Regions (2021-2026)

10.1.2 Americas Vaccine Forecast

10.1.3 APAC Vaccine Forecast

10.1.4 Europe Vaccine Forecast

10.1.5 Middle East & Africa Vaccine Forecast

10.2 Americas Vaccine Forecast by Countries (2021-2026)

10.2.1 United States Vaccine Market Forecast

10.2.2 Canada Vaccine Market Forecast

10.2.3 Mexico Vaccine Market Forecast

10.2.4 Brazil Vaccine Market Forecast

10.3 APAC Vaccine Forecast by Region (2021-2026)

10.3.1 China Vaccine Market Forecast

10.3.2 Japan Vaccine Market Forecast

10.3.3 Korea Vaccine Market Forecast

10.3.4 Southeast Asia Vaccine Market Forecast

10.3.5 India Vaccine Market Forecast

10.3.6 Australia Vaccine Market Forecast

10.4 Europe Vaccine Forecast by Country (2021-2026)

10.4.1 Germany Vaccine Market Forecast

10.4.2 France Vaccine Market Forecast

10.4.3 UK Vaccine Market Forecast

10.4.4 Italy Vaccine Market Forecast

10.4.5 Russia Vaccine Market Forecast

10.5 Middle East & Africa Vaccine Forecast by Region (2021-2026)

10.5.1 Egypt Vaccine Market Forecast

10.5.2 South Africa Vaccine Market Forecast

10.5.3 Israel Vaccine Market Forecast

10.5.4 Turkey Vaccine Market Forecast

10.5.5 GCC Countries Vaccine Market Forecast

10.6 Global Vaccine Forecast by Type (2021-2026)

10.8 Global Vaccine Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 AstraZeneca

11.1.1 AstraZeneca Company Information

11.1.2 AstraZeneca Vaccine Product Offered

11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 AstraZeneca Main Business Overview

11.1.5 AstraZeneca Latest Developments

11.2 BioNTech

11.2.1 BioNTech Company Information

11.2.2 BioNTech Vaccine Product Offered

11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 BioNTech Main Business Overview

11.2.5 BioNTech Latest Developments

11.3 Boehringer-Ingelheim

11.3.1 Boehringer-Ingelheim Company Information

11.3.2 Boehringer-Ingelheim Vaccine Product Offered

11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Boehringer-Ingelheim Main Business Overview

11.3.5 Boehringer-Ingelheim Latest Developments

11.4 CCBIO

11.4.1 CCBIO Company Information

11.4.2 CCBIO Vaccine Product Offered

11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 CCBIO Main Business Overview

11.4.5 CCBIO Latest Developments

11.5 CSL

11.5.1 CSL Company Information

11.5.2 CSL Vaccine Product Offered

11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 CSL Main Business Overview

11.5.5 CSL Latest Developments

11.6 CureVac

11.6.1 CureVac Company Information

11.6.2 CureVac Vaccine Product Offered

11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 CureVac Main Business Overview

11.6.5 CureVac Latest Developments

11.7 Elanco

11.7.1 Elanco Company Information

11.7.2 Elanco Vaccine Product Offered

11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Elanco Main Business Overview

11.7.5 Elanco Latest Developments

11.8 GSK

11.8.1 GSK Company Information

11.8.2 GSK Vaccine Product Offered

11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 GSK Main Business Overview

11.8.5 GSK Latest Developments

11.9 Hulan Bio

11.9.1 Hulan Bio Company Information

11.9.2 Hulan Bio Vaccine Product Offered

11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Hulan Bio Main Business Overview

11.9.5 Hulan Bio Latest Developments

11.10 Indian Immunologicals

11.10.1 Indian Immunologicals Company Information

11.10.2 Indian Immunologicals Vaccine Product Offered

11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Indian Immunologicals Main Business Overview

11.10.5 Indian Immunologicals Latest Developments

11. Merck

11.11.1 Merck Company Information

11.11.2 Merck Vaccine Product Offered

11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Merck Main Business Overview

11.11.5 Merck Latest Developments

11.12 Minhai Biotechnology

11.12.1 Minhai Biotechnology Company Information

11.12.2 Minhai Biotechnology Vaccine Product Offered

11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Minhai Biotechnology Main Business Overview

11.12.5 Minhai Biotechnology Latest Developments

11.13 Mitsubishi Tanabe Pharma

11.13.1 Mitsubishi Tanabe Pharma Company Information

11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered

11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Mitsubishi Tanabe Pharma Main Business Overview

11.13.5 Mitsubishi Tanabe Pharma Latest Developments

11.14 Moderna Therapeutics

11.14.1 Moderna Therapeutics Company Information

11.14.2 Moderna Therapeutics Vaccine Product Offered

11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Moderna Therapeutics Main Business Overview

11.14.5 Moderna Therapeutics Latest Developments

11.15 Mylan

11.15.1 Mylan Company Information

11.15.2 Mylan Vaccine Product Offered

11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Mylan Main Business Overview

11.15.5 Mylan Latest Developments

11.16 Plumbline Life Sciences

11.16.1 Plumbline Life Sciences Company Information

11.16.2 Plumbline Life Sciences Vaccine Product Offered

11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Plumbline Life Sciences Main Business Overview

11.16.5 Plumbline Life Sciences Latest Developments

11.17 Sanofi

11.17.1 Sanofi Company Information

11.17.2 Sanofi Vaccine Product Offered

11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Sanofi Main Business Overview

11.17.5 Sanofi Latest Developments

11.18 Translate Bio

11.18.1 Translate Bio Company Information

11.18.2 Translate Bio Vaccine Product Offered

11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 Translate Bio Main Business Overview

11.18.5 Translate Bio Latest Developments

11.19 Walvax Biotechnology

11.19.1 Walvax Biotechnology Company Information

11.19.2 Walvax Biotechnology Vaccine Product Offered

11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Walvax Biotechnology Main Business Overview

11.19.5 Walvax Biotechnology Latest Developments

11.20 Wuhan Institute of Biological Products

11.20.1 Wuhan Institute of Biological Products Company Information

11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered

11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Wuhan Institute of Biological Products Main Business Overview

11.20.5 Wuhan Institute of Biological Products Latest Developments

11.21 Zoties

11.21.1 Zoties Company Information

11.21.2 Zoties Vaccine Product Offered

11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 Zoties Main Business Overview

11.21.5 Zoties Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Vaccine Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Varicella Vaccine

Table 3. Major Players of Influenza Vaccine

Table 4. Major Players of Polio Vaccine

Table 5. Major Players of Hepatitis A Vaccine

Table 6. Major Players of Rabies Vaccine

Table 7. Major Players of BCG Vaccine

Table 8. Major Players of Hepatitis B

Table 9. Major Players of Pertussis, Diphtheria, Tetanus

Table 10. Major Players of Pneumococcal

Table 11. Major Players of Others

Table 12. Vaccine Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 13. Global Vaccine Market Size by Type (2016-2021) & ($ Millions)

Table 14. Global Vaccine Market Size Market Share by Type (2016-2021)

Table 15. Vaccine Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 16. Global Vaccine Market Size by Application (2016-2021) & ($ Millions)

Table 17. Global Vaccine Market Size Market Share by Application (2016-2021)

Table 18. Global Vaccine Revenue by Players (2019-2021E) & ($ Millions)

Table 19. Global Vaccine Revenue Market Share by Players (2019-2021E)

Table 20. Vaccine Key Players Head office and Products Offered

Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Vaccine Market Size by Regions 2016-2021 & ($ Millions)

Table 25. Global Vaccine Market Size Market Share by Regions 2016-2021

Table 26. Americas Vaccine Market Size by Country (2016-2021) & ($ Millions)

Table 27. Americas Vaccine Market Size Market Share by Country (2016-2021)

Table 28. Americas Vaccine Market Size by Type (2016-2021) & ($ Millions)

Table 29. Americas Vaccine Market Size Market Share by Type (2016-2021)

Table 30. Americas Vaccine Market Size by Application (2016-2021) & ($ Millions)

Table 31. Americas Vaccine Market Size Market Share by Application (2016-2021)

Table 32. APAC Vaccine Market Size by Region (2016-2021) & ($ Millions)

Table 33. APAC Vaccine Market Size Market Share by Region (2016-2021)

Table 34. APAC Vaccine Market Size by Type (2016-2021) & ($ Millions)

Table 35. APAC Vaccine Market Size Market Share by Type (2016-2021)

Table 36. APAC Vaccine Market Size by Application (2016-2021) & ($ Millions)

Table 37. APAC Vaccine Market Size Market Share by Application (2016-2021)

Table 38. Europe Vaccine Market Size by Country (2016-2021) & ($ Millions)

Table 39. Europe Vaccine Market Size Market Share by Country (2016-2021)

Table 40. Europe Vaccine Market Size by Type (2016-2021) & ($ Millions)

Table 41. Europe Vaccine Market Size Market Share by Type (2016-2021)

Table 42. Europe Vaccine Market Size by Application (2016-2021) & ($ Millions)

Table 43. Europe Vaccine Market Size Market Share by Application (2016-2021)

Table 44. Middle East & Africa Vaccine Market Size by Region (2016-2021) & ($ Millions)

Table 45. Middle East & Africa Vaccine Market Size Market Share by Region (2016-2021)

Table 46. Middle East & Africa Vaccine Market Size by Type (2016-2021) & ($ Millions)

Table 47. Middle East & Africa Vaccine Market Size Market Share by Type (2016-2021)

Table 48. Middle East & Africa Vaccine Market Size by Application (2016-2021) & ($ Millions)

Table 49. Middle East & Africa Vaccine Market Size Market Share by Application (2016-2021)

Table 50. Key and Potential Regions of Vaccine

Table 51. Key Application and Potential Industries of Vaccine

Table 52. Key Challenges of Vaccine

Table 53. Key Trends of Vaccine

Table 54. Global Vaccine Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 55. Global Vaccine Market Size Market Share Forecast by Regions (2021-2026)

Table 56. Global Vaccine Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 57. Global Vaccine Market Size Market Share Forecast by Type (2021-2026)

Table 58. Global Vaccine Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 59. Global Vaccine Market Size Market Share Forecast by Application (2021-2026)

Table 60. AstraZeneca Details, Company Type, Vaccine Area Served and Its Competitors

Table 61. AstraZeneca Vaccine Product Offered

Table 62. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. AstraZeneca Main Business

Table 64. AstraZeneca Latest Developments

Table 65. BioNTech Details, Company Type, Vaccine Area Served and Its Competitors

Table 66. BioNTech Vaccine Product Offered

Table 67. BioNTech Main Business

Table 68. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 69. BioNTech Latest Developments

Table 70. Boehringer-Ingelheim Details, Company Type, Vaccine Area Served and Its Competitors

Table 71. Boehringer-Ingelheim Vaccine Product Offered

Table 72. Boehringer-Ingelheim Main Business

Table 73. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 74. Boehringer-Ingelheim Latest Developments

Table 75. CCBIO Details, Company Type, Vaccine Area Served and Its Competitors

Table 76. CCBIO Vaccine Product Offered

Table 77. CCBIO Main Business

Table 78. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 79. CCBIO Latest Developments

Table 80. CSL Details, Company Type, Vaccine Area Served and Its Competitors

Table 81. CSL Vaccine Product Offered

Table 82. CSL Main Business

Table 83. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 84. CSL Latest Developments

Table 85. CureVac Details, Company Type, Vaccine Area Served and Its Competitors

Table 86. CureVac Vaccine Product Offered

Table 87. CureVac Main Business

Table 88. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 89. CureVac Latest Developments

Table 90. Elanco Details, Company Type, Vaccine Area Served and Its Competitors

Table 91. Elanco Vaccine Product Offered

Table 92. Elanco Main Business

Table 93. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 94. Elanco Latest Developments

Table 95. GSK Details, Company Type, Vaccine Area Served and Its Competitors

Table 96. GSK Vaccine Product Offered

Table 97. GSK Main Business

Table 98. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 99. GSK Latest Developments

Table 100. Hulan Bio Details, Company Type, Vaccine Area Served and Its Competitors

Table 101. Hulan Bio Vaccine Product Offered

Table 102. Hulan Bio Main Business

Table 103. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 104. Hulan Bio Latest Developments

Table 105. Indian Immunologicals Details, Company Type, Vaccine Area Served and Its Competitors

Table 106. Indian Immunologicals Vaccine Product Offered

Table 107. Indian Immunologicals Main Business

Table 108. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 109. Indian Immunologicals Latest Developments

Table 110. Merck Details, Company Type, Vaccine Area Served and Its Competitors

Table 111. Merck Vaccine Product Offered

Table 112. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 113. Merck Main Business

Table 114. Merck Latest Developments

Table 115. Minhai Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors

Table 116. Minhai Biotechnology Vaccine Product Offered

Table 117. Minhai Biotechnology Main Business

Table 118. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 119. Minhai Biotechnology Latest Developments

Table 120. Mitsubishi Tanabe Pharma Details, Company Type, Vaccine Area Served and Its Competitors

Table 121. Mitsubishi Tanabe Pharma Vaccine Product Offered

Table 122. Mitsubishi Tanabe Pharma Main Business

Table 123. Mitsubishi Tanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 124. Mitsubishi Tanabe Pharma Latest Developments

Table 125. Moderna Therapeutics Details, Company Type, Vaccine Area Served and Its Competitors

Table 126. Moderna Therapeutics Vaccine Product Offered

Table 127. Moderna Therapeutics Main Business

Table 128. Moderna Therapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 129. Moderna Therapeutics Latest Developments

Table 130. Mylan Details, Company Type, Vaccine Area Served and Its Competitors

Table 131. Mylan Vaccine Product Offered

Table 132. Mylan Main Business

Table 133. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 134. Mylan Latest Developments

Table 135. Plumbline Life Sciences Details, Company Type, Vaccine Area Served and Its Competitors

Table 136. Plumbline Life Sciences Vaccine Product Offered

Table 137. Plumbline Life Sciences Main Business

Table 138. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 139. Plumbline Life Sciences Latest Developments

Table 140. Sanofi Details, Company Type, Vaccine Area Served and Its Competitors

Table 141. Sanofi Vaccine Product Offered

Table 142. Sanofi Main Business

Table 143. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 144. Sanofi Latest Developments

Table 145. Translate Bio Details, Company Type, Vaccine Area Served and Its Competitors

Table 146. Translate Bio Vaccine Product Offered

Table 147. Translate Bio Main Business

Table 148. Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 149. Translate Bio Latest Developments

Table 150. Walvax Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors

Table 151. Walvax Biotechnology Vaccine Product Offered

Table 152. Walvax Biotechnology Main Business

Table 153. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 154. Walvax Biotechnology Latest Developments

Table 155. Wuhan Institute of Biological Products Details, Company Type, Vaccine Area Served and Its Competitors

Table 156. Wuhan Institute of Biological Products Vaccine Product Offered

Table 157. Wuhan Institute of Biological Products Main Business

Table 158. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 159. Wuhan Institute of Biological Products Latest Developments

Table 160. Zoties Details, Company Type, Vaccine Area Served and Its Competitors

Table 161. Zoties Vaccine Product Offered

Table 162. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 163. Zoties Main Business

Table 164. Zoties Latest Developments

List of Figures

Figure 1. Vaccine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Vaccine Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Vaccine Market Size Market Share by Type in 2020

Figure 7. Vaccine in For Adult

Figure 8. Global Vaccine Market: For Adult (2016-2021) & ($ Millions)

Figure 9. Vaccine in For Child

Figure 10. Global Vaccine Market: For Child (2016-2021) & ($ Millions)

Figure 11. Global Vaccine Market Size Market Share by Application in 2020

Figure 12. Global Vaccine Revenue Market Share by Player in 2020

Figure 13. Global Vaccine Market Size Market Share by Regions (2016-2021)

Figure 14. Americas Vaccine Market Size 2016-2021 ($ Millions)

Figure 15. APAC Vaccine Market Size 2016-2021 ($ Millions)

Figure 16. Europe Vaccine Market Size 2016-2021 ($ Millions)

Figure 17. Middle East & Africa Vaccine Market Size 2016-2021 ($ Millions)

Figure 18. Americas Vaccine Market Size Market Share by Country in 2020

Figure 19. Americas Vaccine Market Size Market Share by Type in 2020

Figure 20. Americas Vaccine Market Size Market Share by Application in 2020

Figure 21. United States Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 22. Canada Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 23. Mexico Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 24. APAC Vaccine Market Size Market Share by Regions in 2020

Figure 25. APAC Vaccine Market Size Market Share by Type in 2020

Figure 26. APAC Vaccine Market Size Market Share by Application in 2020

Figure 27. China Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 28. Japan Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 29. Korea Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 30. Southeast Asia Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 31. India Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 32. Australia Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 33. Europe Vaccine Market Size Market Share by Country in 2020

Figure 34. Europe Vaccine Market Size Market Share by Type in 2020

Figure 35. Europe Vaccine Market Size Market Share by Application in 2020

Figure 36. Germany Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 37. France Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 38. UK Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 39. Italy Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 40. Russia Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 41. Middle East & Africa Vaccine Market Size Market Share by Region in 2020

Figure 42. Middle East & Africa Vaccine Market Size Market Share by Type in 2020

Figure 43. Middle East & Africa Vaccine Market Size Market Share by Application in 2020

Figure 44. Egypt Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 45. South Africa Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 46. Israel Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 47. Turkey Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 48. GCC Country Vaccine Market Size Growth 2016-2021 ($ Millions)

Figure 49. Americas Vaccine Market Size 2021-2026 ($ Millions)

Figure 50. APAC Vaccine Market Size 2021-2026 ($ Millions)

Figure 51. Europe Vaccine Market Size 2021-2026 ($ Millions)

Figure 52. Middle East & Africa Vaccine Market Size 2021-2026 ($ Millions)

Figure 53. United States Vaccine Market Size 2021-2026 ($ Millions)

Figure 54. Canada Vaccine Market Size 2021-2026 ($ Millions)

Figure 55. Mexico Vaccine Market Size 2021-2026 ($ Millions)

Figure 56. Brazil Vaccine Market Size 2021-2026 ($ Millions)

Figure 57. China Vaccine Market Size 2021-2026 ($ Millions)

Figure 58. Japan Vaccine Market Size 2021-2026 ($ Millions)

Figure 59. Korea Vaccine Market Size 2021-2026 ($ Millions)

Figure 60. Southeast Asia Vaccine Market Size 2021-2026 ($ Millions)

Figure 61. India Vaccine Market Size 2021-2026 ($ Millions)

Figure 62. Australia Vaccine Market Size 2021-2026 ($ Millions)

Figure 63. Germany Vaccine Market Size 2021-2026 ($ Millions)

Figure 64. France Vaccine Market Size 2021-2026 ($ Millions)

Figure 65. UK Vaccine Market Size 2021-2026 ($ Millions)

Figure 66. Italy Vaccine Market Size 2021-2026 ($ Millions)

Figure 67. Russia Vaccine Market Size 2021-2026 ($ Millions)

Figure 68. Spain Vaccine Market Size 2021-2026 ($ Millions)

Figure 69. Egypt Vaccine Market Size 2021-2026 ($ Millions)

Figure 70. South Africa Vaccine Market Size 2021-2026 ($ Millions)

Figure 71. Israel Vaccine Market Size 2021-2026 ($ Millions)

Figure 72. Turkey Vaccine Market Size 2021-2026 ($ Millions)

Figure 73. GCC Country Vaccine Market Size 2021-2026 ($ Millions)